tiprankstipranks
Relay Therapeutics (RLAY)
NASDAQ:RLAY
US Market

Relay Therapeutics (RLAY) Income Statement

Compare
455 Followers

Relay Therapeutics Income Statement

Last quarter (Q4 2024), Relay Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Relay Therapeutics's net income was $-76.00M. See Relay Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 10.01M$ 25.55M$ 1.38M$ 3.03M$ 82.65M
Gross Profit
$ 10.01M$ 20.28M$ -2.75M$ -896.00K$ 79.11M
Operating Expenses
$ 382.48M$ 398.55M$ 312.33M$ 230.04M$ 138.45M
Depreciation and Amortization
$ 5.46M$ 5.27M$ 4.13M$ 3.92M$ 3.55M
EBITDA
$ -380.21M$ -374.15M$ -306.82M$ -222.18M$ -52.25M
Operating Income
$ -372.47M$ -373.00M$ -299.27M$ -364.70M$ -55.80M
Other Income/Expenses
$ 34.76M$ 31.03M$ 8.77M$ 826.00K$ 3.38M
Pretax Income
$ -337.71M$ -341.97M$ -290.51M$ -363.87M$ -52.41M
Net Income
$ -337.71M$ -341.97M$ -254.26M$ -496.81M$ -49.01M
Per Share Metrics
Basic EPS
$ -2.36$ -2.79$ -2.27$ -5.22$ -1.15
Diluted EPS
$ -2.36$ -2.79$ -2.27$ -5.22$ -1.15
Weighted Average Shares Outstanding
142.87M 122.58M 112.23M 95.14M 42.62M
Weighted Average Shares Outstanding (Diluted)
142.87M 122.58M 112.23M 95.14M 42.62M
Currency in USD

Relay Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis